150
Participants
Start Date
January 21, 2022
Primary Completion Date
December 21, 2025
Study Completion Date
December 21, 2025
SPH5030 tablets
SPH5030 tablets orally once or twice daily.
RECRUITING
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
RECRUITING
Tianjin Medical University Cancer Institute & Hospital, Tianjin
RECRUITING
Anhui provincial hospital, Hefei
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
RECRUITING
Guangxi Cancer Hospital, Nanning
RECRUITING
The Fourth Hospital of Hebei Medical University, Shijiazhuang
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Anyang Cancer Hospital, Anyang
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
Xiangyang Central Hospital, Xiangyang
RECRUITING
Jiangsu Province Hospital, Nanjing
RECRUITING
The First Affiliated Hospital of China Medical University, Shenyang
RECRUITING
Linyi Cancer Hospital, Linyi
RECRUITING
The Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an
RECRUITING
The First Affiliated Hospital of Bengbu Medical University, Bengbu
RECRUITING
The second people's hospital of neijiang, Neijiang
RECRUITING
Tianjin Cancer Hospital Airport Hospital, Tianjin
Shanghai Pharmaceuticals Holding Co., Ltd
INDUSTRY